Financials

News Discussions Technicals Seasonals

2181 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to MABPHARM LTD operating, investing, and financing activities

2181 free cash flow for H1 24 is -85.28 M HKD. For 2023, 2181 free cash flow was 38.79 M HKD and operating cash flow was 59.83 M HKD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—